CorneaGen

CorneaGen is planning to eliminate corneal blindness through research, products, therapeutics, prevention, and policy to transform the corneal ecosystem.

Visit Website

Equinox

Medical device for treatment of Glaucoma patients by balancing intraocular pressure (IOP) with intracranial pressure (ICP)

Visit Website

IanTech

Minimally invasive micro-interventional device to treat cataracts in safe and cost-effective manner without heat-generating vibrational energy or expensive electrically powered equipment.

Visit Website

Mynosys

Zepto, a precision pulse device that creates an accurate and reproducible capsulotomy that is quick, safe, and affordable.

Visit Website

Orasis

Orasis product, CSF-1 is an eye drop currently in clinical development to treat presbyopia. Delivered as a topical solution directly to the eyes, CSF-1 contains a proprietary combination of existing and well-known components with the potential to restore vision in people with presbyopia.

Visit Website

RxSight

Transforming the lens industry by being able to optimize a lens after implantation. RxSight has developed breakthrough intraocular lens technology for use in cataract and lens replacement surgery. Designed by a Nobel Prize winning scientist, RxSights’s Light Adjustable Lens (RxLAL) utilizes light to enable physicians to make office-based refractive adjustments after it has been implanted in the eye.

Visit Website

TearClear

Developed a chemical filter system designed to economically remove BAK at the moment of application to deliver sterile, preservative-free multi-dose ophthalmic drugs.

Visit Website